220 related articles for article (PubMed ID: 32260098)
1. Female AhR Knockout Mice Develop a Minor Renal Insufficiency in an Adenine-Diet Model of Chronic Kidney Disease.
Makhloufi C; Nicolas F; McKay N; Fernandez S; Hache G; Garrigue P; Brunet P; Guillet B; Burtey S; Poitevin S
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260098
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
[TBL] [Abstract][Full Text] [Related]
3. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
[TBL] [Abstract][Full Text] [Related]
4. Blockade of aryl hydrocarbon receptor restricts omeprazole-induced chronic kidney disease.
Sun N; Zhang Y; Ding L; An X; Bai F; Yang Y; Yu K; Fan J; Liu L; Yang H; Yang X
J Mol Med (Berl); 2024 May; 102(5):679-692. PubMed ID: 38453697
[TBL] [Abstract][Full Text] [Related]
5. A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease.
Thome T; Vugman NA; Stone LE; Wimberly K; Scali ST; Ryan TE
JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652558
[TBL] [Abstract][Full Text] [Related]
6. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease.
Walker JA; Richards S; Belghasem ME; Arinze N; Yoo SB; Tashjian JY; Whelan SA; Lee N; Kolachalama VB; Francis J; Ravid K; Sherr D; Chitalia VC
Kidney Int; 2020 Mar; 97(3):538-550. PubMed ID: 31932072
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV attenuates indoxyl sulfate-induced injury of renal tubular epithelial cells by inhibiting the aryl hydrocarbon receptor pathway.
Mo Y; Hu D; Yu W; Ji C; Li Y; Liu X; Lu Z
J Ethnopharmacol; 2023 May; 308():116244. PubMed ID: 36764562
[TBL] [Abstract][Full Text] [Related]
8. Crucial Role of the Aryl Hydrocarbon Receptor (AhR) in Indoxyl Sulfate-Induced Vascular Inflammation.
Ito S; Osaka M; Edamatsu T; Itoh Y; Yoshida M
J Atheroscler Thromb; 2016 Aug; 23(8):960-75. PubMed ID: 26860885
[TBL] [Abstract][Full Text] [Related]
9. Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.
Lu W; Cheng S; Xu J; Xiao Z; Yu Y; Xie Q; Fang Y; Chen R; Shen B; Xie Y; Ding X
Toxicol Lett; 2024 May; 396():81-93. PubMed ID: 38670245
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease induced by an adenine rich diet upregulates integrin linked kinase (ILK) and its depletion prevents the disease progression.
de Frutos S; Luengo A; García-Jérez A; Hatem-Vaquero M; Griera M; O'Valle F; Rodríguez-Puyol M; Rodríguez-Puyol D; Calleros L
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1284-1297. PubMed ID: 30726718
[TBL] [Abstract][Full Text] [Related]
11. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
[TBL] [Abstract][Full Text] [Related]
12. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the aryl hydrocarbon receptor in endothelial cells improves ischemic angiogenesis in chronic kidney disease.
Palzkill VR; Tan J; Yang Q; Morcos J; Laitano O; Ryan TE
Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H44-H60. PubMed ID: 37921663
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells.
Addi T; Poitevin S; McKay N; El Mecherfi KE; Kheroua O; Jourde-Chiche N; de Macedo A; Gondouin B; Cerini C; Brunet P; Dignat-George F; Burtey S; Dou L
Arch Toxicol; 2019 Jan; 93(1):121-136. PubMed ID: 30324315
[TBL] [Abstract][Full Text] [Related]
15. Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease.
Akchurin O; Sureshbabu A; Doty SB; Zhu YS; Patino E; Cunningham-Rundles S; Choi ME; Boskey A; Rivella S
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F877-F889. PubMed ID: 27440777
[TBL] [Abstract][Full Text] [Related]
16. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease.
Arinze NV; Yin W; Lotfollahzadeh S; Napoleon MA; Richards S; Walker JA; Belghasem M; Ravid JD; Hassan Kamel M; Whelan SA; Lee N; Siracuse JJ; Anderson S; Farber A; Sherr D; Francis J; Hamburg NM; Rahimi N; Chitalia VC
J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752422
[TBL] [Abstract][Full Text] [Related]
18. Astrocytic aryl hydrocarbon receptor mediates chronic kidney disease-associated mental disorders involving GLT1 hypofunction and neuronal activity enhancement in the mouse brain.
Huang YJ; Hung CC; Hsu PC; Lee PY; Tsai YA; Hsin YC; Lee XT; Chou CC; Chen ML; Tarng DC; Lee YH
Glia; 2023 Apr; 71(4):1057-1080. PubMed ID: 36573349
[TBL] [Abstract][Full Text] [Related]
19. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan Metabolites Regulate Neuropentraxin 1 Expression in Endothelial Cells.
Vial R; Poitevin S; McKay N; Burtey S; Cerini C
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
